Canada markets closed

Acasti Pharma Inc. (ACST)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
2.9000+0.0300 (+1.05%)
At close: 04:00PM EDT
3.0100 +0.11 (+3.79%)
After hours: 06:35PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-03-31
2022-03-31
2021-03-31
Total Revenue
0
0
0
196
Cost of Revenue
-
-
0
76
Gross Profit
-
-
0
120
Operating Expenses
Research Development
4,638
9,972
5,559
4,173
Selling General and Administrative
7,617
8,212
9,781
6,655
Total Operating Expenses
12,269
18,247
15,340
10,836
Operating Income or Loss
-12,269
-18,247
-15,340
-10,716
Interest Expense
-
-
-
0
Total Other Income/Expenses Net
-37,093
-33,970
4,796
-8,805
Income Before Tax
-48,588
-51,971
-10,467
-19,678
Income Tax Expense
-9,814
-9,542
-648
0
Income from Continuing Operations
-38,774
-42,429
-9,819
-19,678
Net Income
-38,774
-42,429
-9,819
-19,678
Net Income available to common shareholders
-38,774
-42,429
-9,819
-19,678
Basic EPS
-5.65
-5.70
-1.62
-7.98
Diluted EPS
-5.65
-5.70
-1.62
-7.98
Basic Average Shares
7,699
7,435
6,140
2,471
Diluted Average Shares
7,699
7,435
6,140
2,471